Study identification

EU PAS number

EUPAS1000000826

Study ID

1000000826

Official title and acronym

DARWIN EU® - Alzheimer’s Disease: Incidence, Prevalence, and Individuals' Characteristics

DARWIN EU® study

Yes

Study countries

Croatia
Denmark
Germany
Netherlands
United Kingdom

Study description

Alzheimer’s disease (AD) is the most common cause of dementia, characterised by progressive cognitive
decline and loss of independence. Its burden is rising globally due to population ageing, with substantial
implications for healthcare systems and society. Recent therapeutic advances, such as the approval of anti
amyloid monoclonal antibodies, are reshaping AD management but also highlight the need for
comprehensive and updated real-world evidence on the epidemiology and characteristics of affected
populations.
This DARWIN EU® study will provide contextual information through a comprehensive overview of the
incidence and prevalence of AD in the general adult population in European countries, as well as
demographic and clinical characteristics of individuals with AD.

Study status

Ongoing
Research institutions and networks

Institutions

Networks

Contact details

Rana Jajou

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
EMA
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable